AB International Low Volatility Equity ETF
ILOW - ETF AI Analysis
Top Page
AB International Low Volatility Equity ETF (ILOW)
ILOW, the AB International Low Volatility Equity ETF, earns a solid overall rating driven mainly by high-quality global leaders like Novartis and AstraZeneca, which show strong financial performance, healthy balance sheets, and supportive earnings call sentiment. Other sizable positions such as ASML, Roche, Tesco, and Shell add to the fund’s quality through stable operations and generally attractive valuations, though some face valuation concerns or short-term technical weakness. The main risk factor is that several holdings show signs of being expensive or near overbought levels, which could limit upside in the near term.
ILOW vs. SPDR S&P 500 ETF (SPY)
- AUM
- 1.84B
- Region
- Global Ex-U.S.
- Expense Ratio
- 0.50%
- Beta
- 0.61
- Issuer
- AB Funds
- Inception Date
- Jul 15, 2024
- Dividend Yield
- 1.46%
- Asset Class
- Equity
- Index Tracked
- No Underlying Index
ILOW Summary
AB International Low Volatility Equity ETF (ILOW) is a global stock fund that aims to give you broad international exposure while trying to smooth out the ups and downs. It doesn’t track a specific index, but follows a “low volatility” theme by choosing stocks that have historically moved less than the overall market. The fund holds well-known companies like ASML and Shell, along with many others across Europe, Asia, and North America. Someone might invest for diversification and potentially steadier growth. A key risk is that it still owns stocks, so its value can go up and down with global markets.
How much will it cost me?
This ETF has an expense ratio of 0.50%, which means you’ll pay about $5 per year for every $1,000 you invest. That’s higher than the average low-cost index ETF because it’s actively managed and uses a specialized low-volatility strategy, which typically charges more for its research and portfolio management.
What would affect this ETF?
Future performance of this global ex-U.S. low-volatility ETF could benefit from steady economic growth abroad, stable or falling interest rates that support its financial and industrial holdings, and continued demand for defensive sectors like health care and consumer staples, as well as strong results from top companies such as ASML, Shell, Roche, and Novartis. On the downside, rising rates, slower growth or recessions in international markets, regulatory changes affecting energy, financials, or large European firms, and periods when high-risk, high-growth stocks outperform could all weigh on returns despite its focus on lower-volatility stocks.
ILOW Top 10 Holdings
ILOW leans on a mix of steady global blue chips rather than flashy high-fliers. ASML has been a big long-term engine for returns, but its recent wobble shows that even chip leaders can lose their footing. Defensive names like Roche and Novartis are quietly rising, helping smooth out bumps, while Tesco adds a reliable consumer backbone. Shell and OCBC, both climbing, give the fund an energy and financial tailwind. With holdings spread across Europe and Asia and no single sector dominating, the ETF feels more like a balanced international convoy than a concentrated bet.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 NL:ASML | ASML Holding NV | 2.74% | $51.06M | EUR 519.88B | 58.28% | 76Outperform |
 TW:2330 | Taiwan Semiconductor Manufacturing Co., Ltd. | 2.21% | $41.18M | TWD 59.26T | 63.48% | ―― |
 RHHVF | Roche Holding AG | ― | ― | ― | ― | 73Outperform |
 CH:NOVN | Novartis AG | 2.01% | $37.52M | CHF 246.17B | 27.54% | 80Outperform |
 GB:TSCO | Tesco plc | 1.98% | $36.79M | GBP 34.12B | 19.20% | 74Outperform |
 GB:SHEL | Shell (UK) | 1.92% | $35.76M | GBP 205.39B | 25.21% | 73Outperform |
 FR:SU | Schneider Electric | 1.99% | $37.01M | EUR 138.79B | 3.15% | 62Neutral |
 AZN | AstraZeneca | ― | ― | ― | ― | 80Outperform |
 FR:ENX | Euronext NV | 1.74% | $32.38M | EUR 16.09B | 30.78% | 65Neutral |
 SG:O39 | OCBC | 1.84% | $34.29M | SGD 128.53B | 55.36% | 71Outperform |
ILOW Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For ILOW, the sentiment is Positive. The current price of 46.82 is above the 20-day moving average (MA) of 46.34, above the 50-day MA of 46.24, and above the 200-day MA of 45.29, indicating a bullish trend. The MACD of 0.17 indicates Negative momentum. The RSI at 54.92 is Neutral, neither overbought nor oversold. The STOCH value of 76.29 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for ILOW.
ILOW Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| ILOW | $46.82 | $49.00(4.66% Upside) | $1.84B | 0.50% | 61Neutral |
 CGIC | $35.47 | $43.07(21.43% Upside) | $2.57B | 0.54% | 60Neutral |
 WCMI | $18.60 | $23.83(28.11% Upside) | $2.12B | 0.85% | 60Neutral |
 IDVO | $40.07 | $48.15(20.16% Upside) | $1.38B | 0.65% | 65Neutral |
 MFSI | $33.10 | $40.02(20.92% Upside) | $1.29B | 0.59% | 65Neutral |
 APIE | $38.40 | ― | $1.13B | 0.45% | 63Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| ILOW | AB International Low Volatility Equity ETF | 46.82 | 5.15 | 12.37% | |
| CGIC | Capital Group International Core Equity ETF | 35.47 | 4.36 | 14.00% | |
| WCMI | First Trust WCM International Equity ETF | 18.60 | 2.21 | 13.46% | |
| IDVO | Amplify International Enhanced Dividend Income ETF | 40.07 | 4.44 | 12.46% | |
| MFSI | MFS Active International ETF | 33.10 | 3.40 | 11.44% | |
| APIE | ActivePassive International Equity ETF | 38.40 | 3.45 | 9.89% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.